Local risk-minimization with longevity bonds

被引:7
|
作者
Henriksen, Lars Frederik Brandt [1 ]
Moller, Thomas [2 ]
机构
[1] Univ Copenhagen, Dept Math Sci, DK-2100 Copenhagen O, Denmark
[2] PFA Pens, DK-2100 Copenhagen O, Denmark
关键词
longevity bond; minimal martingale measure; local risk-minimization; LIFE-INSURANCE CONTRACTS;
D O I
10.1002/asmb.2028
中图分类号
C93 [管理学]; O22 [运筹学];
学科分类号
070105 ; 12 ; 1201 ; 1202 ; 120202 ;
摘要
This paper studies the criterion of local risk-minimization for life insurance contracts in a financial market, which includes longevity bonds. The longevity bond is a bond specifying payments, which are linked to the current number of survivors in a given portfolio of insured lives. The number of survivors is modeled via a double-stochastic process, where the mortality intensity is driven by a time-inhomogeneous Cox-Ingersoll-Ross model. In addition to the longevity bond, the financial market is assumed to consist of a traditional bond and a savings account. We define the price process of the longevity bond by introducing a pricing measure. The paper extends previous work in the literature to the case where the traded assets are not martingales under the measure used for determining the optimal strategies. We compare our results under the real measure with the former results of globally risk-minimizing strategies, obtained using an equivalent martingale measure. Copyright (c) 2014 John Wiley & Sons, Ltd.
引用
收藏
页码:241 / 263
页数:23
相关论文
共 50 条
  • [41] Seeking Flood Risk-Minimization: How to Benefit from the Use/Availability of Heavy Rainfall-Risk Maps
    Bone, Christian
    Rubinato, Matteo
    Bosseler, Bert
    Schlueter, Marco
    GEOSCIENCES, 2023, 13 (05)
  • [42] Analyzing the Different Modules of Longevity Risk in Death Bonds
    Parnes, Dror
    JOURNAL OF ALTERNATIVE INVESTMENTS, 2019, 21 (03): : 35 - 44
  • [44] Evaluation of Physician Knowledge of the Key Safety Information for Aflibercept in Canada: Evaluation of Risk-Minimization Measures
    Zografos, Laurie J.
    Andrews, Elizabeth
    Wolin, Dan L.
    Calingaert, Brian
    Davenport, Eric K.
    Hollis, Kelly A.
    Djokanovic, Nada
    Racanelli, Vito S.
    Petraro, Paul
    Vassilev, Zdravko P.
    PHARMACEUTICAL MEDICINE, 2019, 33 (03) : 235 - 246
  • [45] Evaluation of Physician Knowledge of the Key Safety Information for Aflibercept in Canada: Evaluation of Risk-Minimization Measures
    Laurie J. Zografos
    Elizabeth Andrews
    Dan L. Wolin
    Brian Calingaert
    Eric K. Davenport
    Kelly A. Hollis
    Nada Djokanovic
    Vito S. Racanelli
    Paul Petraro
    Zdravko P. Vassilev
    Pharmaceutical Medicine, 2019, 33 : 235 - 246
  • [46] Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: Evaluation of Risk-Minimization Measures
    Zografos, Laurie J.
    Andrews, Elizabeth
    Wolin, Daniel L.
    Calingaert, Brian
    Davenport, Eric K.
    Hollis, Kelly A.
    Schmidt-Ott, Ursula Maria
    Petraro, Paul
    Vassilev, Zdravko P.
    PHARMACEUTICAL MEDICINE, 2019, 33 (03) : 219 - 233
  • [47] Continuous-Time Portfolio Selection and Option Pricing under Risk-Minimization Criterion in an Incomplete Market
    Ruan, Xinfeng
    Zhu, Wenli
    Huang, Jiexiang
    Li, Shuang
    JOURNAL OF APPLIED MATHEMATICS, 2013,
  • [48] Ivabradine drug utilization study in five European countries: A pass to assess effectiveness of risk-minimization measures
    Salem, Linda
    Malouvier, Alexandre
    Blathford, Jon
    Rivero-Ferrer, Elena
    Deltour, Nicolas
    Jacquot, Emmanuelle
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 221 - 222
  • [49] Fast infra/inter mode decision for H.264 encoding using a risk-minimization criterion
    Kim, C
    Kuo, CCJ
    APPLICATIONS OF DIGITAL IMAGE PROCESSING XXVII, PTS 1AND 2, 2004, 5558 : 536 - 546
  • [50] Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: Evaluation of Risk-Minimization Measures
    Laurie J. Zografos
    Elizabeth Andrews
    Daniel L. Wolin
    Brian Calingaert
    Eric K. Davenport
    Kelly A. Hollis
    Ursula Maria Schmidt-Ott
    Paul Petraro
    Zdravko P. Vassilev
    Pharmaceutical Medicine, 2019, 33 : 219 - 233